Article
Licensed
Unlicensed
Requires Authentication
Announcement
Published/Copyright:
October 16, 2009
Published Online: 2009-10-16
Published in Print: 1995
Walter de Gruyter
You are currently not able to access this content.
You are currently not able to access this content.
Articles in the same Issue
- Titelei
- Guest editorial
- The oxygen sensor that controls EPO production: facts and fancies
- Serum immunoreactive erythropoietin in health and disease
- Announcement
- The ontogeny of the biological role and production of erythropoietin
- Hemopoietic-initiating cells
- Erythropoiesis in pregnancy
- Iron and erythropoiesis in normal subjects and in pregnancy
- Erythropoiesis in the postpartum period
- Erythropoietin transplacental passage — Review of animal studies
- Lack of permeability of the human placenta for erythropoietin
- Erythropoietin — from gene structure to therapeutic applications
- The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapy
- Recombinant human erythropoietin and parenteral iron in the treatment of pregnancy anemia: a pilot study
- Does recombinant human erythropoietin not only treat anemia but reduce postpartum (emotional) distress as well?
- rhEPO treatment of postpartum anemia
- Recombinant erythropoietin for prevention of anemia in preterm infants
- Erythropoietin therapy for extremely premature infants
- Comparison of high dose therapy of rhEPO, given two or three times a week in premature infants
- The roles and vital importance of placental blood to the newborn infant
Articles in the same Issue
- Titelei
- Guest editorial
- The oxygen sensor that controls EPO production: facts and fancies
- Serum immunoreactive erythropoietin in health and disease
- Announcement
- The ontogeny of the biological role and production of erythropoietin
- Hemopoietic-initiating cells
- Erythropoiesis in pregnancy
- Iron and erythropoiesis in normal subjects and in pregnancy
- Erythropoiesis in the postpartum period
- Erythropoietin transplacental passage — Review of animal studies
- Lack of permeability of the human placenta for erythropoietin
- Erythropoietin — from gene structure to therapeutic applications
- The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapy
- Recombinant human erythropoietin and parenteral iron in the treatment of pregnancy anemia: a pilot study
- Does recombinant human erythropoietin not only treat anemia but reduce postpartum (emotional) distress as well?
- rhEPO treatment of postpartum anemia
- Recombinant erythropoietin for prevention of anemia in preterm infants
- Erythropoietin therapy for extremely premature infants
- Comparison of high dose therapy of rhEPO, given two or three times a week in premature infants
- The roles and vital importance of placental blood to the newborn infant